Now showing items 1-8 of 8

    • Cochran, Mark D.; Collisson, Ellen W.; Choi, In-soo; Winslow, Barbara J.; Cochran, Mark D. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2011-12-06)
      The present invention provides isolated and purified DNA encoding feline CD80 (B7-1) ligand, feline CD86 (B7-2) ligand, feline CD28 receptor, or feline CTLA-4 (CD152) receptor, as well as vectors comprising nucleic acid ...
    • Collisson, Ellen W.; Choi, Insoo; Winslow, Barbara J.; Cochran, Mark D. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2010-06-29)
      The present invention provides isolated and purified DNA encoding feline CD80 (B7-1) ligand, feline CD86 (B7-2) ligand, feline CD28 receptor, or feline CTLA-4 (CD152) receptor, as well as vectors comprising nucleic acid ...
    • Cummins, Joseph M. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 1989-04-11)
      A biologically active interferon can be administered to an animal in conjunction with the administration of a vaccine to improve the vaccine efficiency and allow the use of a smaller vaccination dose. This procedure will ...
    • Collisson, Ellen W.; Choi, Insoo; Winslow, Barbara J.; Cochran, Mark D. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2006-07-18)
      The present invention provides isolated and purified DNA encoding feline CD80 (B7-1) ligand, feline CD86 (B7-2) ligand, feline CD28 receptor, or feline CTLA-4 (CD152) receptor, as well as vectors comprising nucleic acid ...
    • Arntzen, Charles J.; Mason, Hugh S.; Tariq, Haq A.; Clements, John D. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2002-05-28)
      The oral antigens and adjuvants of the present invention are produced in transgenic plants and then administered through the consumption of the transgenic plant. DNA sequences both natural and synthetic encoding for the ...
    • Winslow, Barbara J.; Cochran, Mark D.; Hash, Stephen; Choi, Insoo; Collisson, Ellen (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2007-10-09)
      The present invention involves a recombinant virus which comprises at least one foreign nucleic acid inserted within a non-essential region of the viral genome of a virus, wherein each such foreign nucleic acid encodes a ...
    • Samuel, James E.; Van Schaik, Erin J.; Gregory, Anthony E. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2021-04-06)
      A vaccine includes at least one bacterial antigen capable of producing an immune response in a host when the vaccine is administered at a dose that is sufficient for preventing or treating Q fever in the host. The vaccine ...
    • Faulkner, Olivia B.; Bielke, Lisa; Calhoun, Leona Nicole; Berghman, Luc; Hargis, Billy (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2020-06-16)
      Vaccine compositions including a yeast comprising an immunostimulatory polypeptide and optionally an antigenic polypeptide are provided herein. The immunostimulatory polypeptide and the antigenic polypeptide are expressed ...